CRINETICS PHARMACEUTICALS IN

Ticker: CRNX CUSIP: 22663K107 Class: EQTY

Hillsdale Investment Management Inc.'s Holding History (CIK: 0001368465)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024

Shares 130 Value ($000) $7 Avg Close $51.57 Range $43.71 - $55.78

Q2 2024

Shares 130 Value ($000) $6 Avg Close $46.18 Range $41.01 - $53.70

Q1 2024

Shares 130 Value ($000) $6 Avg Close $39.13 Range $33.67 - $47.58

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2024	130	$7	$51.57	$43.71 - $55.78
Q2 2024	130	$6	$46.18	$41.01 - $53.70
Q1 2024	130	$6	$39.13	$33.67 - $47.58